OrthoTreat

Bone Regeneration Solutions

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2020
Last updated 2026-06-18
Total raised
Last: Grant 2024-07
Stage
Seed
Founded
2020
Headcount
11
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

OrthoTreat believes in empowering healing from within, restoring strength and resilience to people affected by bone-related conditions. Our purpose is to transform lives by tackling one of the most complex challenges in medicine: true bone regeneration.

We've formulated a unique approach, carefully overseeing and modulating the complex processes involved in bone regeneration. By creating a balanced system that precisely controls the immune response, inflammation, and growth factor secretion, we enable natural healing processes to work safely and effectively.

Our flagship product, ModulX, is a dual-drug combination administered as a controlled-release, localized injection with minimal risk factors. ModulX’s sophisticated design accelerates healing, improves bone quality, and offers a new level of care for those in need. With this breakthrough, we’re setting a new standard in bone regeneration, supporting individuals globally in reclaiming mobility and quality of life.

Funding history · 3 rounds · — total

2024-07
Grant Undisclosed
2023-07
Undisclosed
2022-04
Undisclosed

Q&A

What is OrthoTreat's primary focus?
OrthoTreat focuses on bone regeneration solutions, aiming to restore strength and resilience to individuals with bone-related conditions through a unique approach that modulates immune response, inflammation, and growth factor secretion.
What is OrthoTreat's flagship product?
OrthoTreat's flagship product is ModulX, a dual-drug combination administered as a controlled-release, localized injection designed to accelerate healing and improve bone quality.
When was OrthoTreat founded?
OrthoTreat was founded in November 2020.
What is the employee count for OrthoTreat?
OrthoTreat has 11-50 employees.
What is the most recent funding event for OrthoTreat?
OrthoTreat received a Grant in July 2024.
Who are the co-founders of OrthoTreat?
The co-founders of OrthoTreat are Sahar Meiron and Hilik Marom.
What is OrthoTreat's current product stage?
OrthoTreat's product is currently in the R&D stage.
Does OrthoTreat hold any patents?
Yes, OrthoTreat holds 1 patent.

Team · 5

Sahar Meiron
Founder · Chief Executive Officer
LinkedIn ↗
Founder · Co-founder, Pre-Clinical Research & Innovation Director
LinkedIn ↗
Founder · Co-founder, Pre-Clinical Research & Innovation Director
LinkedIn ↗
Founder · Chief Scientific Officer
Founder · Pre-Clinical Research & Innovation Director
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

tissue-regenerationdrug-developmentboneorthopedicsmaterialspharmaceuticalsveterinarytherapeuticsnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteorthotreat.io/
LinkedInlinkedin.com/company/70454761

Identifiers & details

Founded2020-11
Employees (exact)11

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainorthotreat.io

Certificate / subdomain footprint

Subdomains4